I
Ibritumomab
Ibritumomab Tiuxetan
ICRF-187 (Also see Cardioxane? and dexrazoxane) Idamycin?
Idarubicin
Ifex?
IFN-alpha
Ifosfamide
IL-11
IL-2 (Also see: Aldesleukin, rIl-2, Interleukin-2 and Proleukin?)
Imatinib mesylate
Imidazole Carboxamide
Interferon alfa
Interferon Alfa-2b (PEG Conjugate)
Interleukin-2 (Also see: Aldesleukin, IL-2, rIL2 and Proleukin?)
Interleukin-11
Intron A? (interferon alfa-2b)
Iressa?
Irinotecan
Isotretinoin
Istodax? (romidepsin)
A member of a class of cancer drugs known as histone deacetylase (HDAC) inhibitors. HDACs catalyze the removal of acetyl groups from acetylated lysine residues in histones, resulting in the modulation of gene expression. HDACs also deacetylate non-histone proteins, such as transcription factors. HDAC inhibitors can be divided into four main classes: cyclic tetrapeptides (I), short-chain fatty acids (II), hydroxamic acids (III), and benzamides (IV). The cyclic peptide structure of ISTODAX is novel among the cyclic tetrapeptides. In vitro, romidepsin causes the accumulation of acetylated histones, and induces cell cycle arrest and apoptosis of some cancer cell lines. For full prescribing information, visit Istodax?.
Ixabepilone
Ixempra?
J
K
Kidrolase?
L
Lanacort?
Lapatinib
L-asparaginase
LCR
Lenalidomide
Letrozole
Leucovorin
Leukeran
Leukine?
Leuprolide
Leurocristine
Leustatin?
Liposomal Ara-C
Liquid Pred?
Lomustine
L-PAM
L-Sarcolysin
Lupron?
Lupron Depot?
M
Matulane?
Maxidex
Mechlorethamine
Mechlorethamine Hydrochloride
Medralone?
Medrol?
Megace?
Megestrol
Megestrol Acetate
Melphalan
Mercaptopurine
Mesna Mesnex?
Methotrexate
Methotrexate Sodium
Methylprednisolone
Meticorten?
Mitomycin
Mitomycin-C
Mitoxantrone
M-Prednisol?
MTC
MTX
Mustargen?
Mustine
Mutamycin?
Myleran?
Mylocel?
Mylotarg?
Last update: January 14, 2012
